Zhejiang Hisun Pharmaceutical Co., Ltd. predicted that it will suffer a loss in its net profit belonging to shareholders of the company in 2018 compared with RMB 13,566,200 in the same period of the year before, with the net loss belonging to shareholders of the company to be between RMB 410 million and RMB 500 million.